🚀Enjoy a 7-Day Free Trial Until Jul 20, 2024!

QT

Quantrx Biomedical CorpOOTC QTXB Stock Report

Price

Market cap $B

Exchange

OOTC - OTC

FAIR VALUE

Is QTXB undervalued compared to its fair value?

The fair value of QTXB stock is hidden USD. Relative to the market price of 0.004 USD Quantrx Biomedical Corp is hidden.

QuantRx Biomedical Corp. engages in developing and commercializing its patented miniform pads (PADs) and PAD based over-the-counter products for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence...[More about valuation]

Quantrx Biomedical Corp Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0 $B

Price:

0.004 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.001

FINANCIALS

Quantrx Biomedical Corp financial for reporting period

Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0001 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

Balance Sheet

0 B
-0.0028 B

Financial Position Analysis

Assets

0 B
Current Assets
0 B
Total non-current assets

Total current liabilities
0.0028 B
Total non-current liabilities

Cash Flow Statement

0 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Quantrx Biomedical Corp fundamental analysis for trailing twelve months (TTM)

Profitability score


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is QTXB attractive for investment based on fundamental analysis?

QTXB stock rating is hidden. Quantrx Biomedical Corp is a hidden by Eyestock methodology.

Get QTXB Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

QTXB analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for QTXB to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Quantrx Biomedical Corp competitors

AB

ABT

Abbott Laboratories

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The company is headquartered in Abbott Par...

Discover

IS

ISRG

Intuitive Surgical Inc

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company i...

Discover

SY

SYK

Stryker Corp

Stryker Corp. is a medical technology company, which engages in the provision of innovative products and services that help improve patient and healthcare outcomes. The company is ...

Discover

Quantrx Biomedical Corp dividends

QTXB dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About QTXB stock

About the company Quantrx Biomedical Corp

Market cap $B

0

Dividend yield

Shares outstanding

78.6965 B

Website

QuantRx Biomedical Corp. engages in developing and commercializing its patented miniform pads (PADs) and PAD based over-the-counter products for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. The company is headquartered in Tualatin, Oregon. The firm is also developing genomic diagnostics for the laboratory market, based on its lateral flow patents (the Diagnostics Business). The firm's platforms include inSync, Unique and original equipment manufacturer (OEM) branded over-the-counter and laboratory testing products based on its core intellectual property related to the Company PAD technology. Its OTC Business includes commercialization of its InSync feminine hygienic interlabial pad, the Unique Miniform for hemorrhoid application, and other treated miniforms, as well as maintaining established and continuing licensing relationships related to the OTC Business. The company also owns certain diagnostic testing technology that is based on our lateral flow patents.

QTXB profile

  • Ticker

    QTXB

  • Country

    USA

  • Exchange

    OOTC - OTC

  • Report currency

    USD - US dollar

  • IPO date

    31 May 1988

  • Sector

    Healthсare

  • Industry

    Health Care Equipment & Supplies

  • Employees

  • City

    Tualatin

  • Address

    P.O. Box 4960

  • Cusip

    74765N109